Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002)

This study has been withdrawn prior to enrollment.
(Sponsor decision)
Sponsor:
Information provided by:
Tesaro, Inc.
ClinicalTrials.gov Identifier:
NCT01244009
First received: November 17, 2010
Last updated: November 3, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)